Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-088602
Filing Date
2025-06-20
Accepted
2025-06-20 17:42:47
Documents
1
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4750
  Complete submission text file 0000950170-25-088602.txt   6232
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
KAPLAN GILLA (Reporting) CIK: 0001247024 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40800 | Film No.: 251062487

Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Issuer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)